JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

350.08 -1.7

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

346

Max

354.74

Belangrijke statistieken

By Trading Economics

Inkomsten

-1B

-340M

Verkoop

3.1B

84B

K/W

Sectorgemiddelde

44.662

90.422

EPS

3.84

Dividendrendement

0.62

Winstmarge

-0.406

Werknemers

47,000

EBITDA

-1.1B

183M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+14.65% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.62%

2.13%

Volgende Winsten

4 feb 2026

Volgende dividenddatum

2 mrt 2026

Volgende Ex Dividend datum

13 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.9B

69B

Vorige openingsprijs

351.78

Vorige sluitingsprijs

350.08

Nieuwssentiment

By Acuity

58%

42%

294 / 352 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

28 jan 2026, 23:51 UTC

Winsten

Correction to Samsung Fourth-Quarter Net Profit Article

28 jan 2026, 23:49 UTC

Populaire aandelen

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 jan 2026, 23:19 UTC

Winsten

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 jan 2026, 22:43 UTC

Winsten

Waste Management Logs Higher 4Q Profit as Revenue Rises

29 jan 2026, 00:00 UTC

Acquisities, Fusies, Overnames

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29 jan 2026, 00:00 UTC

Acquisities, Fusies, Overnames

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29 jan 2026, 00:00 UTC

Acquisities, Fusies, Overnames

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29 jan 2026, 00:00 UTC

Acquisities, Fusies, Overnames

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28 jan 2026, 23:49 UTC

Marktinformatie

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 jan 2026, 23:30 UTC

Marktinformatie

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 jan 2026, 23:28 UTC

Winsten

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 jan 2026, 23:26 UTC

Winsten

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 jan 2026, 23:21 UTC

Winsten

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 jan 2026, 23:18 UTC

Winsten
Acquisities, Fusies, Overnames

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 jan 2026, 22:58 UTC

Winsten

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 jan 2026, 22:48 UTC

Marktinformatie

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 jan 2026, 22:45 UTC

Winsten

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 jan 2026, 22:44 UTC

Winsten

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 jan 2026, 22:43 UTC

Winsten

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 jan 2026, 22:41 UTC

Winsten
Populaire aandelen

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 jan 2026, 22:41 UTC

Marktinformatie

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 jan 2026, 22:41 UTC

Winsten

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 jan 2026, 22:40 UTC

Winsten

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 jan 2026, 22:39 UTC

Winsten

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 jan 2026, 22:38 UTC

Winsten

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 jan 2026, 22:37 UTC

Winsten

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 jan 2026, 22:35 UTC

Winsten

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 jan 2026, 22:26 UTC

Marktinformatie
Winsten

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 jan 2026, 22:20 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 jan 2026, 22:20 UTC

Marktinformatie

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

14.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 408.3 USD  14.65%

Hoogste 440 USD

Laagste 371 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

294 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat